Effectiveness of Customised 3D-printed Insoles in Reducing Pain Among Frequent Park Runners
The Effectiveness of Customised 3D-printed Insoles on Perceived Pain, Comfort, and Completion Time Among Frequent Park Runners: A Pragmatic Randomised Controlled Trial (The ZOLES Trial)
1 other identifier
interventional
210
1 country
1
Brief Summary
This study evaluates the effectiveness of the Zoles customised 3D-printed insoles to mitigate running-related pain among frequent recreational runners who participate in regular Park Run activities. All participants will have their feet scanned, after which half of the participants will be provided with customised 3D-printed insoles, while the other half will receive no intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pain
Started Sep 2023
Typical duration for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2023
CompletedFirst Posted
Study publicly available on registry
September 13, 2023
CompletedStudy Start
First participant enrolled
September 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 25, 2024
CompletedNovember 26, 2024
November 1, 2024
4 months
September 4, 2023
November 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Running-related Pain
Change in running-related pain from baseline to follow-up during the trial period. Pain is scored on a numeric rating scale from 0 - 10 (0 = No pain at all, 10 = Extremely painful; Salaffi et al., 2004)
10 weeks
Secondary Outcomes (10)
Global Rating of Change (GRoC) in overall daily pain and discomfort
10 weeks
Running-related foot/footwear comfort
10 weeks
5k-completion time
10 weeks
Running-related injuries
10 weeks
Time-loss
10 weeks
- +5 more secondary outcomes
Other Outcomes (6)
Participants achieving MCID reduction in pain
10 weeks
Time until MCID reduction in pain
10 weeks
Change among participants with high baseline pain
10 weeks
- +3 more other outcomes
Study Arms (2)
ZOLES insoles
EXPERIMENTALParticipants allocated to the intervention group will receive customised 3D-printed insoles (Zoles ApS, Espergærde, DK-3060, Denmark) to mitigate running-related pain and discomfort. Being a pragmatic trial, all participants are permitted to continue or initiate any usual care of their choice.
Do-as-usual
NO INTERVENTIONParticipants allocated to the control group are a "do-as-usual" comparator. This implies, that the participants can treat and prevent running-related pain and discomfort in any way they wish, except using the Zoles 3D-printed insoles.
Interventions
Based on measurements from the 3D scanning procedure, and factoring in individual data such as age, weight, and activity preferences, custom insoles are designed using the ZOLA software. The insoles are then 3D-printed by Zoles ApS in Espergærde (Denmark), using BCN3D printers (Barcelona, Spain) and a TPU (Thermoplastic Polyurethane) filament material from Recreus (Alicante, Spain). The printed insoles are tailored for optimal support, performance, and comfort, with varying densities for areas like the arch and heel. They are finished with an OnSteam® microfiber cover for added durability and comfort. The insoles are intended for regular insertion into participants' shoes to align with their unique biomechanical needs. (Information translated and adapted from: https://www.zoles.eu/da/processen-bag-saalerne/)
Eligibility Criteria
You may qualify if:
- Participant is ≥ 35 years old at commencement of trial
- Participant can read, speak and understand English
- Participant can receive e-mails and complete online questionnaires
- Participant is a frequent runner who participate in regular Park Runs
- Participant is capable of running at commencement of trial
You may not qualify if:
- Individuals with severe foot deformities
- Individuals with uncontrolled diabetes with foot complications, or other conditions that might interfere with their ability to safely use the insoles and participate in running activities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Mary's University, Twickenhamlead
- Copenhagen University Hospital, Hvidovrecollaborator
- Aalborg Universitycollaborator
- Zoles ApScollaborator
Study Sites (1)
St Mary's University, Faculty of Sport, Technology and Health Sciences
Twickenham, London, TW1 4SX, United Kingdom
Related Publications (1)
Ibrahim S, Djurtoft C, Mellor R, Thorborg K, Lysdal FG. The effectiveness of customised 3D-printed insoles on perceived pain, comfort, and completion time among frequent Park Runners: Study protocol for a pragmatic randomised controlled trial (The ZOLES RCT). Foot (Edinb). 2024 Mar;58:102068. doi: 10.1016/j.foot.2024.102068. Epub 2024 Feb 6.
PMID: 38350194BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Filip Gertz Lysdal, MSc, PhD
Faculty of Sport, Technology and Health Sciences, St Mary's University, United Kingdom
- PRINCIPAL INVESTIGATOR
Suleyman Ibrahim, MEd
Faculty of Sport, Technology and Health Sciences, St Mary's University, United Kingdom
- STUDY CHAIR
Chris Djurtoft, PT, MSc
Department of Clinical Medicine, Aalborg University, Denmark
- STUDY CHAIR
Rik Mellor, MSc
Faculty of Sport, Technology and Health Sciences, St Mary's University, United Kingdom
- STUDY CHAIR
Kristian Thorborg, PT, MSc, PhD
Sports Orthopaedic Research Center-Copenhagen (SORC-C), Department of Orthopaedic Surgery, Copenhagen University Hospital, Amager-Hvidovre, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2023
First Posted
September 13, 2023
Study Start
September 16, 2023
Primary Completion
January 2, 2024
Study Completion
November 25, 2024
Last Updated
November 26, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share